Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study

医学 肝细胞癌 倾向得分匹配 微波消融 肝切除术 内科学 外科 肿瘤科 放射科 切除术 烧蚀
作者
Wenqiang Wang,Xing Lv,Jian Li,Jiang Li,Jinlin Wang,Tong Yuan,Junjie Liu,Rong-Hua Zhu,Zhiyong Huang,Erlei Zhang
出处
期刊:Ejso [Elsevier BV]
卷期号:49 (5): 1001-1008 被引量:13
标识
DOI:10.1016/j.ejso.2022.12.016
摘要

Repeat hepatectomy (RH) and microwave ablation (MWA) are frequently used procedures for the treatment of recurrent hepatocellular carcinoma (HCC) after curative resection. This study aimed to compare the long-term outcomes of RH and MWA for solitary and small HCC with early or late recurrence.This retrospective study enrolled patients who underwent RH or MWA for solitary and small (≤3 cm) recurrent HCC at Tongji hospital between April 2006 and December 2020. Propensity score matching (PSM) was further employed to analyze the prognosis of different treatment methods.A total of 256 patients were analyzed, of whom 94 and 162 underwent RH and MWA, respectively. The overall treatment-related complication rate was higher in the RH group. Both recurrence-free survival (RFS) and overall survival (OS) rates of RH were significantly better than those of MWA. Multivariate analysis showed that MWA, early recurrence (within 24 months after initial resection), cirrhosis, and AFP >400 ng/ml were independent risk factors for poor prognoses of recurrent HCC. The stratified analysis demonstrated that MWA and RH had similar long-term outcomes in patients with early recurrence. Nevertheless, MWA had worse RFS and OS than RH in patients with late recurrence. The same results were obtained in the PSM analysis.The long-term outcomes of HCC patients with late recurrence were significantly better than those with early recurrence. RH should be the first choice for solitary small recurrent HCC patients with late recurrence, while MWA should be selected for those with early recurrence.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
研友_ZGjRjn发布了新的文献求助10
1秒前
Summer完成签到,获得积分10
2秒前
慕容誉发布了新的文献求助10
2秒前
3秒前
Jasper应助dagger采纳,获得10
3秒前
宗帝完成签到,获得积分10
5秒前
5秒前
科研通AI2S应助平常囧采纳,获得10
5秒前
6秒前
actor2006发布了新的文献求助10
6秒前
7秒前
小蘑菇应助一台机器采纳,获得10
8秒前
大黑发布了新的文献求助10
8秒前
10秒前
羊群发布了新的文献求助10
12秒前
辰辰完成签到,获得积分20
12秒前
零伊依发布了新的文献求助10
13秒前
13秒前
14秒前
YGYANG发布了新的文献求助10
14秒前
16秒前
17秒前
18秒前
dagger发布了新的文献求助10
19秒前
20秒前
00完成签到,获得积分10
20秒前
刘丰丰完成签到,获得积分10
20秒前
隐形曼青应助小糕同学采纳,获得10
21秒前
风中水香完成签到,获得积分10
21秒前
舒适翠柏发布了新的文献求助10
22秒前
面壁思过发布了新的文献求助10
24秒前
25秒前
李__完成签到,获得积分10
26秒前
27秒前
杜妤涵完成签到,获得积分10
27秒前
双双完成签到 ,获得积分10
29秒前
平常囧发布了新的文献求助10
30秒前
31秒前
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6361593
求助须知:如何正确求助?哪些是违规求助? 8175396
关于积分的说明 17222316
捐赠科研通 5416388
什么是DOI,文献DOI怎么找? 2866330
邀请新用户注册赠送积分活动 1843584
关于科研通互助平台的介绍 1691450